{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:32:14Z","timestamp":1791613934209,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ijrobp.2009.10.008","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T07:25:19Z","timestamp":1271057119000},"page":"195-201","source":"Crossref","is-referenced-by-count":142,"title":["Confirmation of a Low \u03b1\/\u03b2 Ratio for Prostate Cancer Treated by External Beam Radiation Therapy Alone Using a Post-Treatment Repeated-Measures Model for PSA Dynamics"],"prefix":"10.1016","volume":"79","author":[{"given":"C\u00e9cile","family":"Proust-Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"S\u00e9cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Kestin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungwha","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2009.10.008_bib1","first-page":"747","article-title":"What is the alpha\/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy","volume":"44","author":"Duchesne","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0360-3016(03)00132-9","article-title":"What hypofractionated protocols should be tested for prostate cancer?","volume":"56","author":"Fowler","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clon.2007.02.007","article-title":"Is the alpha\/beta value for prostate tumours low enough to be safely used in clinical trials?","volume":"19","author":"Dasu","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is alpha\/beta for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2006.12.036","article-title":"Use of individual fraction size data from 3756 patients to directly determine the alpha\/beta ratio of prostate cancer","volume":"68","author":"Williams","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0167-8140(00)00291-7","article-title":"High dose rate prostate brachytherapy: The California Endocurietherapy (CET) method","volume":"57","author":"Demanes","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0360-3016(99)00455-1","article-title":"Higher than standard radiation doses (> or = 72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer","volume":"46","author":"Kupelian","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0360-3016(00)00436-3","article-title":"Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: The William Beaumont phase II dose-escalating trial","volume":"47","author":"Martinez","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","article-title":"How low is the alpha\/beta ratio for prostate cancer?","volume":"55","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0360-3016(03)01456-1","article-title":"Hypofractionation for prostate cancer radiotherapy\u2014What are the issues?","volume":"57","author":"Brenner","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib13","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2005.06.009","article-title":"The alpha\/beta ratio for prostate cancer: What is it, really?","volume":"76","author":"Bentzen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2008.01.056","article-title":"Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts","volume":"72","author":"Proust-Lima","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1200\/JCO.2005.12.156","article-title":"Individualized predictions of disease progression following radiation therapy for prostate cancer","volume":"23","author":"Taylor","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ijrobp.2004.05.026","article-title":"Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I\/II dose-escalation study","volume":"60","author":"Roach","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2005.12.007","article-title":"An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk","volume":"65","author":"Williams","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib19","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2","article-title":"Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy","volume":"86","author":"Kestin","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ijrobp.2004.04.048","article-title":"Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer","volume":"60","author":"Williams","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0360-3016(03)00439-5","article-title":"Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias","volume":"57","author":"Pickles","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/biostatistics\/kxp009","article-title":"Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: A joint modeling approach","volume":"10","author":"Proust-Lima","year":"2009","journal-title":"Biostatistics"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.annepidem.2007.10.006","article-title":"Hierarchical changepoint models for biochemical markers illustrated by tracking postradiotherapy prostate-specific antigen series in men with prostate cancer","volume":"18","author":"Bellera","year":"2008","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib25","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1002\/sim.1392","article-title":"Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes","volume":"21","author":"Pauler","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/1097-0142(19910715)68:2<400::AID-CNCR2820680231>3.0.CO;2-Z","article-title":"A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy","volume":"68","author":"Kaplan","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0360-3016(93)90429-Y","article-title":"Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time","volume":"27","author":"Hanks","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.04.049","article-title":"Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma","volume":"69","author":"Martin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-8140(98)00061-9","article-title":"The relationship between biochemical failure and time to nadir in patients treated with external beam therapy for T1-T3 prostate carcinoma","volume":"48","author":"Aref","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2009.10.008_bib30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ijrobp.2005.07.006","article-title":"PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis","volume":"64","author":"Ray","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609033410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609033410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:50:12Z","timestamp":1544575812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301609033410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0360301609033410"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2009.10.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}